Welcome to our dedicated page for GENCOR INDUSTRIES SEC filings (Ticker: GENC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENCOR INDUSTRIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENCOR INDUSTRIES's regulatory disclosures and financial reporting.
Gencor Industries, Inc. (NYSE American: GENC) filed an 8-K dated 25 Jul 2025 to disclose that it has issued a press release announcing its fiscal 1Q 2025 results. The earnings release is furnished as Exhibit 99.1; no financial figures are included within the filing itself. Management states the information is being furnished, not filed, thereby limiting legal incorporation into other SEC documents. No other material events, transactions, or changes in control are reported.
Gencor Industries (NYSE:GENC) filed its overdue Annual Report for FY ended September 30 2024. The filing reveals two auditor changes: MSL partners joined Forvis Mazars on Nov 1 2024; Forvis Mazars was then dismissed on Feb 13 2025 and replaced by Berkowitz Pollack Brant on Feb 20 2025. Auditor turnover delayed completion of the FY 2024 audit and ICFR attestation, resulting in late Form 10-K and outstanding Form 10-Qs for the quarters ended Dec 31 2024 and Mar 31 2025.
Consequently, the company received a NYSE American delinquency notice. The exchange has now granted an extension until August 19 2025 to file all missing reports and regain compliance, mitigating immediate delisting risk.
Capital structure: as of June 25 2025 the company had 12.34 M common shares and 2.32 M Class B shares outstanding; non-affiliate market value at Q2 FY24 was $160.2 million.
No restatements, going-concern warnings, or material changes to business operations were disclosed in this report.
Gencor Industries (NYSE:GENC) filed an 8-K under Item 2.02 – Results of Operations and Financial Condition on 27 Jun 2025, furnishing its FY-2024 and Q4-2024 earnings press release as Exhibit 99.1. The information is deemed “furnished,” limiting Section 18 liability, and is not incorporated into other filings unless later referenced. No additional items, financial statements or strategic updates were included. Investors should consult Exhibit 99.1 for detailed revenue, profit and cash-flow figures.
Gencor Industries (NYSE:GENC) filed an 8-K (Item 3.01) announcing it remains non-compliant with NYSE American listing standards because its FY-2024 Form 10-K and two Form 10-Qs are still delinquent. The exchange has accepted the company’s plan and granted an extension to August 19 2025; the final 12-month cure deadline is December 30 2025. Failure to meet interim milestones or the ultimate deadline will trigger delisting proceedings. Management "expects" to file the 10-K by June 30 2025 and the outstanding 10-Qs by the new cure date but gives no assurance. A press release (Ex. 99.1) and forward-looking statements outlining geopolitical and supply-chain risks accompany the filing.